RF – Tildrakizumab 200mg. Is Double Dosing Really a Window of Opportunity?

Background Although psoriasis prevalence varies by region, age and sex, there is a lack of comprehensive data for Spain. This study used data from the National Health System Primary Care Clinical Database (BDCAP) for 2023 […]

Background Numerous studies have investigated the association that exists between genetic variants and the efficacy profile of biologic therapies for the management of psoriasis. However, as far as we know, data on this association for […]